Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-05-000014
Filing Date
2005-05-13
Accepted
2005-05-13 13:44:20
Documents
1
Period of Report
2005-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3836
  Complete submission text file 0000882796-05-000014.txt   5646
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O CONNETICS CORP 3290 WEST BAYSHORE ROAD PALO ALTO CA 94303 6508432800
HIGGINS JOHN L (Reporting) CIK: 0001208906 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 05828046